These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19219944)

  • 1. Aggressive medical therapy can reverse atherosclerosis. Research shows that lifestyle changes and medications can help remove dangerous plaque from your arteries.
    Heart Advis; 2008 Sep; 11(9):4-5. PubMed ID: 19219944
    [No Abstract]   [Full Text] [Related]  

  • 2. [Not Available].
    Parhofer KG
    MMW Fortschr Med; 2018 Jan; 160(1):38-39. PubMed ID: 29335945
    [No Abstract]   [Full Text] [Related]  

  • 3. A paradigm shift in the treatment of atherosclerosis.
    Ferrières J
    Arch Cardiovasc Dis; 2015; 108(6-7):337-9. PubMed ID: 26148633
    [No Abstract]   [Full Text] [Related]  

  • 4. Residual risk for secondary ischemic events in patients with atherothrombotic disease: opportunity for future improvements in patient care.
    Pepine CJ
    Ann Med; 2010; 42(1):19-35. PubMed ID: 20092398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia Panel.
    Anderson TJ; Grégoire J; Hegele RA; Couture P; Mancini GB; McPherson R; Francis GA; Poirier P; Lau DC; Grover S; Genest J; Carpentier AC; Dufour R; Gupta M; Ward R; Leiter LA; Lonn E; Ng DS; Pearson GJ; Yates GM; Stone JA; Ur E
    Can J Cardiol; 2014 Apr; 30(4):377-80. PubMed ID: 24589194
    [No Abstract]   [Full Text] [Related]  

  • 6. Statins and stroke prevention.
    Paciaroni M; Hennerici M; Agnelli G; Bogousslavsky J
    Cerebrovasc Dis; 2007; 24(2-3):170-82. PubMed ID: 17596685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin receptor blockers on myocardial infarction: what are we to believe?
    Ker JA; Rheeder P
    Cardiovasc J S Afr; 2005; 16(2):81-2. PubMed ID: 15915272
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonfatal outcomes in the primary prevention of atherosclerotic cardiovascular disease: is all-cause mortality really all that matters?
    Czarny MJ; Martin SS; Kohli P; Metkus T; Blumenthal RS
    Circ Cardiovasc Qual Outcomes; 2014 May; 7(3):481-5. PubMed ID: 24714601
    [No Abstract]   [Full Text] [Related]  

  • 9. Journal Watch: evidence that Atorvastatin reduces the risk of stroke and myocardial infarction in patients with type 2 diabetes, but with no evidence of dyslipidaemia.
    Gangaidzo IT
    Cent Afr J Med; 2005; 51(11-12):125-6. PubMed ID: 17447346
    [No Abstract]   [Full Text] [Related]  

  • 10. Interpreting and evaluating the details of the JUPITER study.
    Neft M
    Am Fam Physician; 2010 Sep; 82(6):571-7; author reply 571-7. PubMed ID: 20842982
    [No Abstract]   [Full Text] [Related]  

  • 11. Statin therapy in ARAS: beyond cholesterol lowering.
    Meier P
    Am J Hypertens; 2008 Oct; 21(10):1075. PubMed ID: 18806771
    [No Abstract]   [Full Text] [Related]  

  • 12. Trial stopped early after rosuvastatin found to cut the risk of heart attack and stroke by 44% in healthy people.
    Dobson R
    BMJ; 2008 Nov; 337():a2523. PubMed ID: 19004893
    [No Abstract]   [Full Text] [Related]  

  • 13. An International Atherosclerosis Society position paper: global recommendations for the management of dyslipidemia: executive summary.
    Expert Panel on Dyslipidemia
    Atherosclerosis; 2014 Feb; 232(2):410-3. PubMed ID: 24468156
    [No Abstract]   [Full Text] [Related]  

  • 14. [Secondary prevention of patients with ischaemic heart disease--the reduction of LDL cholesterol level and the regression of atherosclerosis].
    Bárczi G; Merkely B
    Lege Artis Med; 2007 Oct; 17(10):675-9. PubMed ID: 19227597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the evidence of statin treatment to reduce plaque vulnerability.
    Montecucco F; Pende A
    Drug Metab Lett; 2012 Sep; 6(3):151-6. PubMed ID: 23276200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.
    Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Hoffman E; Goto S; Ohman EM; Bhatt DL;
    Am J Med; 2013 Aug; 126(8):693-700.e1. PubMed ID: 23800583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stroke, cholesterol and statins--are there new data about stroke prevention?].
    Ferbert A
    Dtsch Med Wochenschr; 2001 Jun; 126(22):664-70. PubMed ID: 11450627
    [No Abstract]   [Full Text] [Related]  

  • 18. Vitamin D and cardiovascular disease: From atherosclerosis to myocardial infarction and stroke.
    Muscogiuri G; Annweiler C; Duval G; Karras S; Tirabassi G; Salvio G; Balercia G; Kimball S; Kotsa K; Mascitelli L; Bhattoa HP; Colao A
    Int J Cardiol; 2017 Mar; 230():577-584. PubMed ID: 28043680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and risk of new-onset diabetes mellitus.
    Shah RV; Goldfine AB
    Circulation; 2012 Oct; 126(18):e282-4. PubMed ID: 23109518
    [No Abstract]   [Full Text] [Related]  

  • 20. Beneficial effects of statins on perioperative cardiovascular outcome.
    Dunkelgrun M; Schouten O; Feringa HH; Vidakovic R; Poldermans D
    Curr Opin Anaesthesiol; 2006 Aug; 19(4):418-22. PubMed ID: 16829724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.